Literature DB >> 16288980

Unveiling hidden features of orphan nuclear receptors: the case of the small heterodimer partner (SHP).

Antonio Macchiarulo1, Giovanni Rizzo, Gabriele Costantino, Stefano Fiorucci, Roberto Pellicciari.   

Abstract

The small heterodimer partner (SHP) is an atypical nuclear receptor lacking the N-terminal ligand-independent activation domain and the DNA binding domain. SHP acts as transcriptional inhibitor of a large set of nuclear receptors, among which ER, AR, CAR, RXR, GR, LXR and ERRgamma. The repression mechanism of SHP involves several actions including competition with coactivators binding on the AF-2 of nuclear receptors and recruitment of transcriptional inhibitors such as EID-1. The investigation of the structure and repression mechanism of SHP is a challenging task for a full understanding of nuclear receptor interaction pathways and functions. So far, mutational analyses in multiple populations identified loss of function mutants of SHP gene involved in mild obesity, increased birth weight and insulin levels. Furthermore, experimental mutagenesis has been exploited to characterize the interactions between SHP and the transcriptional inhibitor EID-1. With the aim of gaining insight into the structural basis of SHP repression mechanism, we modelled SHP and EID-1 structures. Docking experiments were carried out to identify the EID-1 binding surface on SHP structure. The results obtained in this study allow for the first time a unique interpretation of many experimental data available from the published literature. In addition, a fascinating hypothesis raises from the inspection of the proposed SHP structure: the presence of a potential unexpected ligand binding site, supported by recently available experimental data that may represent a breakthrough in the design and development of synthetic modulators of SHP functions.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16288980     DOI: 10.1016/j.jmgm.2005.09.016

Source DB:  PubMed          Journal:  J Mol Graph Model        ISSN: 1093-3263            Impact factor:   2.518


  9 in total

Review 1.  microRNAs as regulators of adipogenic differentiation of mesenchymal stem cells.

Authors:  Dana Hamam; Dalia Ali; Moustapha Kassem; Abdullah Aldahmash; Nehad M Alajez
Journal:  Stem Cells Dev       Date:  2014-12-31       Impact factor: 3.272

2.  Adamantyl-substituted retinoid-related molecules bind small heterodimer partner and modulate the Sin3A repressor.

Authors:  Lulu Farhana; Marcia I Dawson; Mark Leid; Li Wang; David D Moore; Gang Liu; Zeben Xia; Joseph A Fontana
Journal:  Cancer Res       Date:  2007-01-01       Impact factor: 12.701

3.  Increased EID1 nuclear translocation impairs synaptic plasticity and memory function associated with pathogenesis of Alzheimer's disease.

Authors:  Rugao Liu; Joy X Lei; Chun Luo; Xun Lan; Liying Chi; Panyue Deng; Saobo Lei; Othman Ghribi; Qing Yan Liu
Journal:  Neurobiol Dis       Date:  2011-12-11       Impact factor: 5.996

4.  Insights into the binding mode and mechanism of action of some atypical retinoids as ligands of the small heterodimer partner (SHP).

Authors:  Marco Cellanetti; Viswanath Gunda; Li Wang; Antonio Macchiarulo; Roberto Pellicciari
Journal:  J Comput Aided Mol Des       Date:  2010-09-30       Impact factor: 3.686

5.  Novel polymorphisms of nuclear receptor SHP associated with functional and structural changes.

Authors:  Taofeng Zhou; Yuxia Zhang; Antonio Macchiarulo; Zhihong Yang; Marco Cellanetti; Eliecer Coto; Pingyi Xu; Roberto Pellicciari; Li Wang
Journal:  J Biol Chem       Date:  2010-06-01       Impact factor: 5.157

6.  Structural Analysis of the Glucocorticoid Receptor Ligand-Binding Domain in Complex with Triamcinolone Acetonide and a Fragment of the Atypical Coregulator, Small Heterodimer Partner.

Authors:  Emily R Weikum; C Denise Okafor; Emma H D'Agostino; Jennifer K Colucci; Eric A Ortlund
Journal:  Mol Pharmacol       Date:  2017-04-10       Impact factor: 4.436

7.  Adamantyl-substituted retinoid-derived molecules that interact with the orphan nuclear receptor small heterodimer partner: effects of replacing the 1-adamantyl or hydroxyl group on inhibition of cancer cell growth, induction of cancer cell apoptosis, and inhibition of SRC homology 2 domain-containing protein tyrosine phosphatase-2 activity.

Authors:  Marcia I Dawson; Zebin Xia; Tao Jiang; Mao Ye; Joseph A Fontana; Lulu Farhana; Bhaumik Patel; Li Ping Xue; Mohammad Bhuiyan; Roberto Pellicciari; Antonio Macchiarulo; Roberto Nuti; Xiao-Kun Zhang; Young-Hoon Han; Lutz Tautz; Peter D Hobbs; Ling Jong; Nahid Waleh; Wan-Ru Chao; Gen-Sheng Feng; Yuhong Pang; Ying Su
Journal:  J Med Chem       Date:  2008-08-30       Impact factor: 7.446

8.  Structural insights into gene repression by the orphan nuclear receptor SHP.

Authors:  Xiaoyong Zhi; X Edward Zhou; Yuanzheng He; Christoph Zechner; Kelly M Suino-Powell; Steven A Kliewer; Karsten Melcher; David J Mangelsdorf; H Eric Xu
Journal:  Proc Natl Acad Sci U S A       Date:  2013-12-30       Impact factor: 11.205

9.  Molecular and macromolecular alterations of recombinant adenoviral vectors do not resolve changes in hepatic drug metabolism during infection.

Authors:  Shellie M Callahan; Piyanuch Wonganan; Maria A Croyle
Journal:  Virol J       Date:  2008-09-30       Impact factor: 4.099

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.